Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis.
Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis.
复制标题
DOI:
10.1182/blood-2009-05-223057
复制
发表时间:
2010-05
期刊:
影响因子:
20.3
通讯作者:
A. Tanaka;F. Itoh;Koichi Nishiyama;T. Takezawa;H. Kurihara;S. Itoh;Mitsuyasu Kato
中科院分区:
文献类型:
--
作者:
A. Tanaka;F. Itoh;Koichi Nishiyama;T. Takezawa;H. Kurihara;S. Itoh;Mitsuyasu Kato
E2-2 belongs to the basic helix-loop-helix (bHLH) family of transcription factors. E2-2 associates with inhibitor of DNA binding (Id) 1, which is involved in angiogenesis. In this paper, we demonstrate that E2-2 interacts with Id1 and provide evidence that this interaction potentiates angiogenesis. Mutational analysis revealed that the HLH domain of E2-2 is required for the interaction with Id1 and vice versa. In addition, Id1 interfered with E2-2-mediated effects on luciferase reporter activities. Interestingly, injection of E2-2-expressing adenoviruses into Matrigel plugs implanted under the skin blocked in vivo angiogenesis. In contrast, the injection of Id1-expressing adenoviruses rescued E2-2-mediated inhibition of in vivo angiogenic reaction. Consistent with the results of the Matrigel plug assay, E2-2 could inhibit endothelial cell (EC) migration, network formation, and proliferation. On the other hand, knockdown of E2-2 in ECs increased EC migration. The blockade of EC migration by E2-2 was relieved by exogenous expression of Id1. We also demonstrated that E2-2 can perturb VEGFR2 expression via inhibition of VEGFR2 promoter activity. This study suggests that E2-2 can maintain EC quiescence and that Id1 can counter this effect.